Medical Molecular Morphology, ISSN 1860-1480, 12/2010, Volume 43, Issue 4, pp. 231 - 234
Acquired cystic disease (ACD)-associated renal cell carcinoma (RCC) has been recently described. To date, there are no reports on genetic findings of G-band...
Pathology | Medical Microbiology | Biomedicine | Acquired cystic disease | Renal cell carcinoma | Biological Microscopy | Molecular Medicine | Chromosomes 3 and 16 | KIDNEYS | NEOPLASMS | ABNORMALITIES | IN-SITU HYBRIDIZATION | PATHOLOGY | TUMORS | Kidney Neoplasms - genetics | Carcinoma, Renal Cell - pathology | Humans | Carcinoma, Renal Cell - genetics | Male | Chromosomes, Human, Pair 7 | Kidney Diseases, Cystic - pathology | Chromosomes, Human, X | Karyotyping - methods | Chromosomes, Human, Pair 3 | Chromosomes, Human, Y | Chromosome Aberrations | Chromosomes, Human, Pair 16 | Kidney Diseases, Cystic - genetics | Kidney Neoplasms - pathology | Aged | Genetic aspects | Carcinoma, Renal cell | Oxalates | Oxalic acid | Histology | Kidney diseases | Cytoplasm | Cancer | Tumors
Pathology | Medical Microbiology | Biomedicine | Acquired cystic disease | Renal cell carcinoma | Biological Microscopy | Molecular Medicine | Chromosomes 3 and 16 | KIDNEYS | NEOPLASMS | ABNORMALITIES | IN-SITU HYBRIDIZATION | PATHOLOGY | TUMORS | Kidney Neoplasms - genetics | Carcinoma, Renal Cell - pathology | Humans | Carcinoma, Renal Cell - genetics | Male | Chromosomes, Human, Pair 7 | Kidney Diseases, Cystic - pathology | Chromosomes, Human, X | Karyotyping - methods | Chromosomes, Human, Pair 3 | Chromosomes, Human, Y | Chromosome Aberrations | Chromosomes, Human, Pair 16 | Kidney Diseases, Cystic - genetics | Kidney Neoplasms - pathology | Aged | Genetic aspects | Carcinoma, Renal cell | Oxalates | Oxalic acid | Histology | Kidney diseases | Cytoplasm | Cancer | Tumors
Journal Article
Nephrology Dialysis Transplantation, ISSN 0931-0509, 05/2012, Volume 27, Issue suppl 2, pp. ii378 - ii399
Journal Article
Blood, ISSN 0006-4971, 2009, Volume 114, Issue 8, pp. 1607 - 1617
KW-2449, a multikinase inhibitor of FLT3, ABL, ABL-T315I, and Aurora kinase, is under investigation to treat leukemia patients. In this study, we examined its...
PATHWAYS | ACTIVATING MUTATION | IN-VITRO | HEMATOPOIESIS | IMATINIB | TYROSINE KINASE INHIBITOR | ACUTE MYELOID-LEUKEMIA | COMBINATION | HEMATOLOGY | CHEMOTHERAPY | INSIGHTS | Leukemia - pathology | Humans | Cells, Cultured | Male | Mice, SCID | Piperazines - pharmacology | Isoleucine - genetics | Mice, Inbred C3H | Indazoles - pharmacology | fms-Like Tyrosine Kinase 3 - genetics | Fusion Proteins, bcr-abl - genetics | Mutation, Missense - physiology | Animals | Proto-Oncogene Proteins c-bcr - genetics | Threonine - genetics | K562 Cells | HL-60 Cells | Antineoplastic Agents - pharmacology | Cell Proliferation - drug effects | Mice | Protein Kinase Inhibitors - pharmacology | Drug Evaluation, Preclinical | Leukemia - genetics | Translocation, Genetic - genetics
PATHWAYS | ACTIVATING MUTATION | IN-VITRO | HEMATOPOIESIS | IMATINIB | TYROSINE KINASE INHIBITOR | ACUTE MYELOID-LEUKEMIA | COMBINATION | HEMATOLOGY | CHEMOTHERAPY | INSIGHTS | Leukemia - pathology | Humans | Cells, Cultured | Male | Mice, SCID | Piperazines - pharmacology | Isoleucine - genetics | Mice, Inbred C3H | Indazoles - pharmacology | fms-Like Tyrosine Kinase 3 - genetics | Fusion Proteins, bcr-abl - genetics | Mutation, Missense - physiology | Animals | Proto-Oncogene Proteins c-bcr - genetics | Threonine - genetics | K562 Cells | HL-60 Cells | Antineoplastic Agents - pharmacology | Cell Proliferation - drug effects | Mice | Protein Kinase Inhibitors - pharmacology | Drug Evaluation, Preclinical | Leukemia - genetics | Translocation, Genetic - genetics
Journal Article
International Journal of Oncology, ISSN 1019-6439, 03/2015, Volume 46, Issue 3, pp. 963 - 972
Shikonin (SHK), a natural small agent (MW 288.3), reportedly induces cell death in various tumor cells. We have found that SHK also exerts potent cytocidal...
Necroptosis | Heat shock protein | Multiple myeloma | Apoptosis | Proteasome | proteasome | multiple myeloma | ACTIVATION | CANCER CELLS | INDUCED APOPTOSIS | DOWN-REGULATION | apoptosis | heat shock protein | DEATH | INDUCTION | IDENTIFICATION | LINES | ONCOLOGY | PATHWAY | STRESS | necroptosis | Apoptosis - drug effects | Purine Nucleosides - pharmacology | Humans | Cell Line, Tumor - drug effects | Antineoplastic Agents - administration & dosage | Necrosis - pathology | X-Box Binding Protein 1 | Dose-Response Relationship, Drug | Multiple Myeloma - drug therapy | Indoles - pharmacology | Antineoplastic Agents - pharmacology | Naphthoquinones - administration & dosage | Cell Death - drug effects | Bortezomib | Endoplasmic Reticulum Stress - drug effects | Proteasome Inhibitors - pharmacology | Naphthoquinones - pharmacology | Imidazoles - pharmacology | Transcription Factors - genetics | DNA-Binding Proteins - genetics | Regulatory Factor X Transcription Factors | Multiple Myeloma - pathology | Pyrazines - pharmacology | Boronic Acids - pharmacology | Drug Resistance, Neoplasm - drug effects
Necroptosis | Heat shock protein | Multiple myeloma | Apoptosis | Proteasome | proteasome | multiple myeloma | ACTIVATION | CANCER CELLS | INDUCED APOPTOSIS | DOWN-REGULATION | apoptosis | heat shock protein | DEATH | INDUCTION | IDENTIFICATION | LINES | ONCOLOGY | PATHWAY | STRESS | necroptosis | Apoptosis - drug effects | Purine Nucleosides - pharmacology | Humans | Cell Line, Tumor - drug effects | Antineoplastic Agents - administration & dosage | Necrosis - pathology | X-Box Binding Protein 1 | Dose-Response Relationship, Drug | Multiple Myeloma - drug therapy | Indoles - pharmacology | Antineoplastic Agents - pharmacology | Naphthoquinones - administration & dosage | Cell Death - drug effects | Bortezomib | Endoplasmic Reticulum Stress - drug effects | Proteasome Inhibitors - pharmacology | Naphthoquinones - pharmacology | Imidazoles - pharmacology | Transcription Factors - genetics | DNA-Binding Proteins - genetics | Regulatory Factor X Transcription Factors | Multiple Myeloma - pathology | Pyrazines - pharmacology | Boronic Acids - pharmacology | Drug Resistance, Neoplasm - drug effects
Journal Article
IEEE Transactions on Applied Superconductivity, ISSN 1051-8223, 04/2016, Volume 26, Issue 3, pp. 1 - 5
Liquid hydrogen (LH 2 ) has excellent properties such as large latent heat, low viscosity, and so on. Because of these properties, LH 2 is expected to be used...
Temperature | wire | Critical current density (superconductivity) | Wires | Heating | Superconducting filaments and wires | Over-current Properties | Magnetic fields | Liquid hydrogen | Transient analysis | MgB2 | MgB | Computer simulation | Superconductors
Temperature | wire | Critical current density (superconductivity) | Wires | Heating | Superconducting filaments and wires | Over-current Properties | Magnetic fields | Liquid hydrogen | Transient analysis | MgB2 | MgB | Computer simulation | Superconductors
Journal Article
Experimental Gerontology, ISSN 0531-5565, 10/2018, Volume 111, pp. 27 - 34
Arterial stiffness increases with advancing age, and is as an emerging biomarker in the assessment of vascular health. Some studies suggest that high-intensity...
Arterial stiffness | Combined training | Resistance training | Older men | Exercise order | Aerobic exercise | C-REACTIVE PROTEIN | OXIDATIVE STRESS | CARDIOVASCULAR EVENTS | RANDOMIZED CONTROLLED-TRIAL | HUMAN ENDOTHELIAL-CELLS | BLOOD-PRESSURE | HYPERTENSIVE PATIENTS | GERIATRICS & GERONTOLOGY | HABITUAL EXERCISE | NITRIC-OXIDE | POSTMENOPAUSAL WOMEN | Physiological aspects | Wave propagation | Sports sciences | Heart beat | Weight training
Arterial stiffness | Combined training | Resistance training | Older men | Exercise order | Aerobic exercise | C-REACTIVE PROTEIN | OXIDATIVE STRESS | CARDIOVASCULAR EVENTS | RANDOMIZED CONTROLLED-TRIAL | HUMAN ENDOTHELIAL-CELLS | BLOOD-PRESSURE | HYPERTENSIVE PATIENTS | GERIATRICS & GERONTOLOGY | HABITUAL EXERCISE | NITRIC-OXIDE | POSTMENOPAUSAL WOMEN | Physiological aspects | Wave propagation | Sports sciences | Heart beat | Weight training
Journal Article
Physics Procedia, ISSN 1875-3892, 2015, Volume 67, pp. 631 - 636
Hydrogen film boiling heat transfer coefficients were measured for the heater surface superheats up to 400 K under pressures from 400 to 1100 kPa, liquid...
Annulus | Forced convection | Film boiling | Liquid hydrogen
Annulus | Forced convection | Film boiling | Liquid hydrogen
Journal Article
IEEE Transactions on Applied Superconductivity, ISSN 1051-8223, 08/2019, Volume 29, Issue 5, pp. 1 - 5
We have been developing a liquid hydrogen (LH 2 ) cooled superconducting energy apparatus, such as superconducting generator, SMES, and so on. An MgB 2...
Temperature measurement | quench behavior | Temperature | Critical current density (superconductivity) | Wires | Hydrogen | _{2} solenoid coil">MgB _{2} solenoid coil | Superconducting magnets | Magnetic fields | Liquid hydrogen | coil load line | PHYSICS, APPLIED | MgB2 solenoid coil | ENGINEERING, ELECTRICAL & ELECTRONIC | Coils | Cooling | Equipment costs | Superconductivity | Wire | Magnesium compounds | Production costs | Borides | Immersion cooling | Excitation | Critical temperature
Temperature measurement | quench behavior | Temperature | Critical current density (superconductivity) | Wires | Hydrogen |
Journal Article
Physics Procedia, ISSN 1875-3892, 2015, Volume 67, pp. 637 - 642
In this report, we show results on the forced flow boiling heat transfer experiments for manganin plate pasted on one side of a rectangular duct. Nucleate...
Forced Flow | Liquid Hydrogen | Heat Transfer
Forced Flow | Liquid Hydrogen | Heat Transfer
Journal Article
Menopause, ISSN 1072-3714, 06/2018, Volume 25, Issue 6, pp. 668 - 675
OBJECTIVE:This study aimed to examine the effects of exercise order of combined aerobic and low- or moderate-intensity resistance training into the same...
Older women | Muscle strength | Combined training | Training intensity | Exercise order | Functional capacity | CONCURRENT STRENGTH | METABOLIC SYNDROME | EXERCISE SEQUENCE | RANDOMIZED CONTROLLED-TRIAL | COMBINED ENDURANCE | OBSTETRICS & GYNECOLOGY | SKELETAL-MUSCLE | ARTERIAL COMPLIANCE | OBESE ADULTS | ELDERLY-MEN | POSTMENOPAUSAL WOMEN | Aged women | Aerobic exercises | Weight training for women | Health aspects | Methods | Body composition
Older women | Muscle strength | Combined training | Training intensity | Exercise order | Functional capacity | CONCURRENT STRENGTH | METABOLIC SYNDROME | EXERCISE SEQUENCE | RANDOMIZED CONTROLLED-TRIAL | COMBINED ENDURANCE | OBSTETRICS & GYNECOLOGY | SKELETAL-MUSCLE | ARTERIAL COMPLIANCE | OBESE ADULTS | ELDERLY-MEN | POSTMENOPAUSAL WOMEN | Aged women | Aerobic exercises | Weight training for women | Health aspects | Methods | Body composition
Journal Article
IEEE Transactions on Applied Superconductivity, ISSN 1051-8223, 08/2019, Volume 29, Issue 5, pp. 1 - 6
Developing applications of liquid-hydrogen (LH 2 )-cooled superconducting devices is a challenging issue. Since the boiling point of LH 2 is 20.4 K, MgB 2 ,...
Heating systems | Temperature measurement | Integrated circuits | normal zone propagation | Cooling | Critical current density (superconductivity) | Wires | minimum quench energy | Magnetic fields | Liquid hydrogen | MgB2 wire | PHYSICS, APPLIED | HEAT-TRANSFER | ENGINEERING, ELECTRICAL & ELECTRONIC | Superconducting devices | Temperature distribution | Propagation velocity | Propagation | Computer simulation | Equipment costs | Superconductivity | Wire | Magnesium compounds | Thermal stability | Finite element method | Borides | Simulation | Boiling points | Critical temperature | Normal zone propagation
Heating systems | Temperature measurement | Integrated circuits | normal zone propagation | Cooling | Critical current density (superconductivity) | Wires | minimum quench energy | Magnetic fields | Liquid hydrogen | MgB2 wire | PHYSICS, APPLIED | HEAT-TRANSFER | ENGINEERING, ELECTRICAL & ELECTRONIC | Superconducting devices | Temperature distribution | Propagation velocity | Propagation | Computer simulation | Equipment costs | Superconductivity | Wire | Magnesium compounds | Thermal stability | Finite element method | Borides | Simulation | Boiling points | Critical temperature | Normal zone propagation
Journal Article
Blood Cancer Journal, ISSN 2044-5385, 07/2012, Volume 2, Issue 7, pp. e79 - e79
The IRE1 alpha-XBP1 pathway, a key component of the endoplasmic reticulum (ER) stress response, is considered to be a critical regulator for survival of...
ER stress | Toyocamycin | XBP1 | Adenosine analog | IRE1α | Multiple myeloma | multiple myeloma | ACTIVATION | UNFOLDED-PROTEIN RESPONSE | KINASE | ENDOPLASMIC-RETICULUM STRESS | CLEAVAGE | adenosine analog | ONCOLOGY | toyocamycin | IRE1 alpha | IRE1 | GENE-EXPRESSION | DIFFERENTIATION | TRANSCRIPTION FACTOR ATF6 | PROTEASOME INHIBITORS | Original
ER stress | Toyocamycin | XBP1 | Adenosine analog | IRE1α | Multiple myeloma | multiple myeloma | ACTIVATION | UNFOLDED-PROTEIN RESPONSE | KINASE | ENDOPLASMIC-RETICULUM STRESS | CLEAVAGE | adenosine analog | ONCOLOGY | toyocamycin | IRE1 alpha | IRE1 | GENE-EXPRESSION | DIFFERENTIATION | TRANSCRIPTION FACTOR ATF6 | PROTEASOME INHIBITORS | Original
Journal Article
Scientific Reports, ISSN 2045-2322, 12/2018, Volume 8, Issue 1, pp. 4029 - 14
Clinical and experimental studies have shown that sodium glucose co-transporter 2 inhibitors (SGLT2i) contribute to the prevention of diabetic kidney disease...
NADPH OXIDASE | GLUCOSE-TRANSPORTER | MULTIDISCIPLINARY SCIENCES | INJURY | COTRANSPORTER 2 INHIBITION | HYPOXIA | BLOOD-PRESSURE | EMPAGLIFLOZIN | Glucose transporter | Oxidative stress | Excretion | Kidneys | Diabetes mellitus | Albumin | Glucose | NAD(P)H oxidase | Molecular modelling | Nephropathy | Sodium | Rodents | Hypoxia | Diabetes | Hemodynamics | Kidney diseases | Oxygen tension | Renal cortex | Hypertrophy
NADPH OXIDASE | GLUCOSE-TRANSPORTER | MULTIDISCIPLINARY SCIENCES | INJURY | COTRANSPORTER 2 INHIBITION | HYPOXIA | BLOOD-PRESSURE | EMPAGLIFLOZIN | Glucose transporter | Oxidative stress | Excretion | Kidneys | Diabetes mellitus | Albumin | Glucose | NAD(P)H oxidase | Molecular modelling | Nephropathy | Sodium | Rodents | Hypoxia | Diabetes | Hemodynamics | Kidney diseases | Oxygen tension | Renal cortex | Hypertrophy
Journal Article
TRANSLATIONAL LUNG CANCER RESEARCH, ISSN 2218-6751, 08/2019, Volume 8, Issue 4, pp. 450 - 450
Background: Current clinical trials demonstrated that combination regimens comprising chemotherapy and immunotherapy lead to better patient outcomes compared...
MULTICENTER | PD-L1 EXPRESSION | programmed death-ligand 1 | MONOCLONAL-ANTIBODY | OPEN-LABEL | ATEZOLIZUMAB | non-small cell lung cancer (NSCLC) | ramucirumab (Ram) | PEMBROLIZUMAB | ONCOLOGY | RESPIRATORY SYSTEM | REGULATORY T-CELLS | Docetaxel (Doc) | NIVOLUMAB | PHASE-I | retrospective study | NSCLC PATIENTS | Original
MULTICENTER | PD-L1 EXPRESSION | programmed death-ligand 1 | MONOCLONAL-ANTIBODY | OPEN-LABEL | ATEZOLIZUMAB | non-small cell lung cancer (NSCLC) | ramucirumab (Ram) | PEMBROLIZUMAB | ONCOLOGY | RESPIRATORY SYSTEM | REGULATORY T-CELLS | Docetaxel (Doc) | NIVOLUMAB | PHASE-I | retrospective study | NSCLC PATIENTS | Original
Journal Article
Medicine, ISSN 0025-7974, 10/2018, Volume 97, Issue 40, p. e12660
Non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutation show a high response to EGFR-tyrosine kinase inhibitor...
EGFR mutation | EGFR-TKI resistance | Afatinib | NSCLC | CARBOPLATIN-PACLITAXEL | 1ST-LINE TREATMENT | GEFITINIB | MULTICENTER | ADENOCARCINOMA | PHASE-III | OPEN-LABEL | CHEMOTHERAPY | afatinib | MEDICINE, GENERAL & INTERNAL | ERLOTINIB | Lung Neoplasms - genetics | Lung Neoplasms - drug therapy | Receptor, Epidermal Growth Factor - genetics | Prospective Studies | Carcinoma, Non-Small-Cell Lung - genetics | Humans | Disease-Free Survival | Protein Kinase Inhibitors - therapeutic use | Quinazolines - therapeutic use | Proteomics | Protein Kinase Inhibitors - pharmacology | Carcinoma, Non-Small-Cell Lung - drug therapy | Quinazolines - pharmacology | Research Design | Drug Resistance, Neoplasm - drug effects | Genetic aspects | Lung cancer, Non-small cell | Drug therapy | Drug resistance
EGFR mutation | EGFR-TKI resistance | Afatinib | NSCLC | CARBOPLATIN-PACLITAXEL | 1ST-LINE TREATMENT | GEFITINIB | MULTICENTER | ADENOCARCINOMA | PHASE-III | OPEN-LABEL | CHEMOTHERAPY | afatinib | MEDICINE, GENERAL & INTERNAL | ERLOTINIB | Lung Neoplasms - genetics | Lung Neoplasms - drug therapy | Receptor, Epidermal Growth Factor - genetics | Prospective Studies | Carcinoma, Non-Small-Cell Lung - genetics | Humans | Disease-Free Survival | Protein Kinase Inhibitors - therapeutic use | Quinazolines - therapeutic use | Proteomics | Protein Kinase Inhibitors - pharmacology | Carcinoma, Non-Small-Cell Lung - drug therapy | Quinazolines - pharmacology | Research Design | Drug Resistance, Neoplasm - drug effects | Genetic aspects | Lung cancer, Non-small cell | Drug therapy | Drug resistance
Journal Article
Cryogenics, ISSN 0011-2275, 06/2018, Volume 92, pp. 105 - 117
Heat transfer from inner side of a heated vertical pipe to liquid hydrogen flowing upward was measured at the pressures of 0.4, 0.7 and 1.1 MPa for wide ranges...
Nitrogen | Hydrogen | DNB heat flux | Heat transfer | Forced flow | PHYSICS, APPLIED | THERMODYNAMICS | TUBES | GENERALIZED CORRELATION | Nuclear energy | Analysis
Nitrogen | Hydrogen | DNB heat flux | Heat transfer | Forced flow | PHYSICS, APPLIED | THERMODYNAMICS | TUBES | GENERALIZED CORRELATION | Nuclear energy | Analysis
Journal Article
Leukemia, ISSN 0887-6924, 01/2010, Volume 24, Issue 1, pp. 33 - 43
Treatment using Fms-like tyrosine kinase-3 (FLT3) inhibitors is a promising approach to overcome the dismal prognosis of acute myeloid leukemia (AML) with...
AML | MDM2 | FLT3 | Apoptosis | P53 | SURVIVAL | P53-DEPENDENT APOPTOSIS | MUTANT FLT3 | ACUTE MYELOGENOUS LEUKEMIA | apoptosis | ACUTE MYELOID-LEUKEMIA | BH3 MIMETIC ABT-737 | p53 | ONCOLOGY | RESISTANCE | INTERNAL TANDEM DUPLICATIONS | HEMATOLOGY | EXPRESSION | fms-Like Tyrosine Kinase 3 - antagonists & inhibitors | Proto-Oncogene Proteins c-bcl-2 - physiology | Apoptosis - drug effects | Leukemia, Myeloid, Acute - pathology | Humans | bcl-2-Associated X Protein - metabolism | Imidazoles - pharmacology | G1 Phase - drug effects | Pyrimidines - pharmacology | Piperazines - pharmacology | Proteasome Endopeptidase Complex - physiology | Tumor Suppressor Protein p53 - physiology | fms-Like Tyrosine Kinase 3 - genetics | Myeloid Cell Leukemia Sequence 1 Protein | Cell Line, Tumor | Leukemia, Myeloid, Acute - drug therapy | Proto-Oncogene Proteins c-bcl-2 - antagonists & inhibitors | Pyridines - pharmacology | Mutation | Doxorubicin - pharmacology | Leukemia, Myeloid, Acute - genetics | Protein tyrosine kinase | Chemotherapy | Genetic aspects | Tumor proteins | Health aspects | Cancer
AML | MDM2 | FLT3 | Apoptosis | P53 | SURVIVAL | P53-DEPENDENT APOPTOSIS | MUTANT FLT3 | ACUTE MYELOGENOUS LEUKEMIA | apoptosis | ACUTE MYELOID-LEUKEMIA | BH3 MIMETIC ABT-737 | p53 | ONCOLOGY | RESISTANCE | INTERNAL TANDEM DUPLICATIONS | HEMATOLOGY | EXPRESSION | fms-Like Tyrosine Kinase 3 - antagonists & inhibitors | Proto-Oncogene Proteins c-bcl-2 - physiology | Apoptosis - drug effects | Leukemia, Myeloid, Acute - pathology | Humans | bcl-2-Associated X Protein - metabolism | Imidazoles - pharmacology | G1 Phase - drug effects | Pyrimidines - pharmacology | Piperazines - pharmacology | Proteasome Endopeptidase Complex - physiology | Tumor Suppressor Protein p53 - physiology | fms-Like Tyrosine Kinase 3 - genetics | Myeloid Cell Leukemia Sequence 1 Protein | Cell Line, Tumor | Leukemia, Myeloid, Acute - drug therapy | Proto-Oncogene Proteins c-bcl-2 - antagonists & inhibitors | Pyridines - pharmacology | Mutation | Doxorubicin - pharmacology | Leukemia, Myeloid, Acute - genetics | Protein tyrosine kinase | Chemotherapy | Genetic aspects | Tumor proteins | Health aspects | Cancer
Journal Article
CURRENT PHARMACEUTICAL DESIGN, ISSN 1381-6128, 01/2013, Volume 19, Issue 3, pp. 366 - 376
Heat shock protein (Hsp) 90 is an ATP-dependent molecular chaperone which stabilizes various oncogenic kinases, including HER2, EGFR, BCR-ABL, B-Raf and...
MULTIPLE-MYELOMA | TYROSINE KINASE | BCR-ABL | SELECTIVE DEPLETION | PROTEIN 90 INHIBITOR | ANTITUMOR-ACTIVITY | Hsp90 | molecular target therapeutics | BREAST-CANCER | MOLECULAR CHAPERONE | HERBIMYCIN-A | PHARMACOLOGY & PHARMACY | cancer | ERYTHROID-DIFFERENTIATION | Neoplasms - metabolism | Humans | Drug Discovery - trends | Morpholines - pharmacology | Drug Discovery - methods | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - chemistry | Morpholines - chemistry | Neoplasms - drug therapy | Animals | HSP90 Heat-Shock Proteins - antagonists & inhibitors | HSP90 Heat-Shock Proteins - metabolism | Antineoplastic Agents - pharmacology | Morpholines - therapeutic use | Molecular target therapeutics | Cancer
MULTIPLE-MYELOMA | TYROSINE KINASE | BCR-ABL | SELECTIVE DEPLETION | PROTEIN 90 INHIBITOR | ANTITUMOR-ACTIVITY | Hsp90 | molecular target therapeutics | BREAST-CANCER | MOLECULAR CHAPERONE | HERBIMYCIN-A | PHARMACOLOGY & PHARMACY | cancer | ERYTHROID-DIFFERENTIATION | Neoplasms - metabolism | Humans | Drug Discovery - trends | Morpholines - pharmacology | Drug Discovery - methods | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - chemistry | Morpholines - chemistry | Neoplasms - drug therapy | Animals | HSP90 Heat-Shock Proteins - antagonists & inhibitors | HSP90 Heat-Shock Proteins - metabolism | Antineoplastic Agents - pharmacology | Morpholines - therapeutic use | Molecular target therapeutics | Cancer
Journal Article